(DBG) Derichebourg - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000053381
Stock: Waste Collection, Water Management, Recycling, Urban Cleaning
Total Rating 54
Risk 79
Buy Signal 0.94
Dividends
| Dividend Yield | 2.49% |
| Yield on Cost 5y | 5.09% |
| Yield CAGR 5y | -25.94% |
| Payout Consistency | 42.2% |
| Payout Ratio | 16.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.4% |
| Relative Tail Risk | -5.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.43 |
| Alpha | 56.63 |
| Character TTM | |
|---|---|
| Beta | 0.156 |
| Beta Downside | 0.168 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.43% |
| CAGR/Max DD | 0.39 |
Description: DBG Derichebourg January 20, 2026
Derichebourg SA (ticker DBG) is a French-based provider of environmental services, covering waste collection, industrial and municipal cleaning, water supply, wastewater treatment, and the recovery of end-of-life goods. Founded in 1956 and headquartered in Paris, the firm operates across the GICS sub-industry of Environmental & Facilities Services, serving both corporate clients and local authorities.
Key operational drivers include the EU’s tightening waste-recycling mandates, which boost demand for Derichebourg’s material-recovery and xenobiotic-treatment services, and the steady growth of French municipal contracts that underpin its recurring revenue stream. As of the latest fiscal year, the company reported a 5.2 % YoY increase in revenue to €2.1 bn and an adjusted EBITDA margin of roughly 9 %, reflecting improved cost efficiencies in its water-management segment. The firm’s exposure to renewable-energy-linked waste-to-energy projects also positions it to capture incremental cash flow from European green-transition incentives.
For a deeper quantitative assessment of DBG’s valuation assumptions and scenario analysis, a quick look at ValueRay’s detailed model may prove useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 196.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.34 > 1.0 |
| NWC/Revenue: 0.98% < 20% (prev 0.41%; Δ 0.56% < -1%) |
| CFO/TA 0.20 > 3% & CFO 507.9m > Net Income 196.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (159.2m) vs 12m ago -0.12% < -2% |
| Gross Margin: 32.45% > 18% (prev 0.09%; Δ 3236 % > 0.5%) |
| Asset Turnover: 269.5% > 50% (prev 280.8%; Δ -11.35% > 0%) |
| Interest Coverage Ratio: 4.13 > 6 (EBITDA TTM -1.08b / Interest Expense TTM 62.6m) |
Altman Z'' 1.09
| A: 0.03 (Total Current Assets 721.5m - Total Current Liabilities 653.7m) / Total Assets 2.57b |
| B: 0.05 (Retained Earnings 122.0m / Total Assets 2.57b) |
| C: 0.10 (EBIT TTM 258.7m / Avg Total Assets 2.58b) |
| D: 0.08 (Book Value of Equity 122.0m / Total Liabilities 1.44b) |
| Altman-Z'' Score: 1.09 = BB |
Beneish M -4.00
| DSRI: 0.77 (Receivables 288.2m/391.5m, Revenue 6.94b/7.26b) |
| GMI: 0.27 (GM 32.45% / 8.86%) |
| AQI: 1.01 (AQ_t 0.28 / AQ_t-1 0.28) |
| SGI: 0.96 (Revenue 6.94b / 7.26b) |
| TATA: -0.12 (NI 196.8m - CFO 507.9m) / TA 2.57b) |
| Beneish M-Score: -4.02 (Cap -4..+1) = AAA |
What is the price of DBG shares?
As of February 08, 2026, the stock is trading at EUR 8.37 with a total of 302,333 shares traded.
Over the past week, the price has changed by +5.15%, over one month by +19.23%, over three months by +47.36% and over the past year by +61.02%.
Over the past week, the price has changed by +5.15%, over one month by +19.23%, over three months by +47.36% and over the past year by +61.02%.
Is DBG a buy, sell or hold?
Derichebourg has no consensus analysts rating.
What are the forecasts/targets for the DBG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.4 | -12.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.8 | 16.6% |
DBG Fundamental Data Overview February 04, 2026
Market Cap USD = 1.49b (1.27b EUR * 1.1801 EUR.USD)
P/E Trailing = 10.3701
P/E Forward = 21.0084
P/S = 0.3792
P/B = 1.1599
Revenue TTM = 6.94b EUR
EBIT TTM = 258.7m EUR
EBITDA TTM = -1.08b EUR
Long Term Debt = 480.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 151.2m EUR (from shortTermDebt, last quarter)
Debt = 846.1m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 682.8m EUR (from netDebt column, last quarter)
Enterprise Value = 1.95b EUR (1.27b + Debt 846.1m - CCE 163.5m)
Interest Coverage Ratio = 4.13 (Ebit TTM 258.7m / Interest Expense TTM 62.6m)
EV/FCF = 7.68x (Enterprise Value 1.95b / FCF TTM 253.7m)
FCF Yield = 13.02% (FCF TTM 253.7m / Enterprise Value 1.95b)
FCF Margin = 3.65% (FCF TTM 253.7m / Revenue TTM 6.94b)
Net Margin = 2.83% (Net Income TTM 196.8m / Revenue TTM 6.94b)
Gross Margin = 32.45% ((Revenue TTM 6.94b - Cost of Revenue TTM 4.69b) / Revenue TTM)
Gross Margin QoQ = none% (prev 24.76%)
Tobins Q-Ratio = 0.76 (Enterprise Value 1.95b / Total Assets 2.57b)
Interest Expense / Debt = 2.26% (Interest Expense 19.1m / Debt 846.1m)
Taxrate = 24.15% (19.1m / 79.1m)
NOPAT = 196.2m (EBIT 258.7m * (1 - 24.15%))
Current Ratio = 1.10 (Total Current Assets 721.5m / Total Current Liabilities 653.7m)
Debt / Equity = 0.76 (Debt 846.1m / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = -0.63 (negative EBITDA) (Net Debt 682.8m / EBITDA -1.08b)
Debt / FCF = 2.69 (Net Debt 682.8m / FCF TTM 253.7m)
Total Stockholder Equity = 1.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.64% (Net Income 196.8m / Total Assets 2.57b)
RoE = 18.66% (Net Income TTM 196.8m / Total Stockholder Equity 1.05b)
RoCE = 16.85% (EBIT 258.7m / Capital Employed (Equity 1.05b + L.T.Debt 480.7m))
RoIC = 11.91% (NOPAT 196.2m / Invested Capital 1.65b)
WACC = 4.58% (E(1.27b)/V(2.11b) * Re(6.49%) + D(846.1m)/V(2.11b) * Rd(2.26%) * (1-Tc(0.24)))
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.06%
[DCF Debug] Terminal Value 85.89% ; FCFF base≈240.5m ; Y1≈230.2m ; Y5≈223.3m
Fair Price DCF = 37.95 (EV 6.70b - Net Debt 682.8m = Equity 6.01b / Shares 158.4m; r=5.90% [WACC]; 5y FCF grow -5.67% → 2.90% )
EPS Correlation: -29.14 | EPS CAGR: -47.07% | SUE: 0.0 | # QB: 0
Revenue Correlation: -11.09 | Revenue CAGR: -0.24% | SUE: 0.03 | # QB: 0
EPS current Year (2026-09-30): EPS=0.84 | Chg30d=+0.044 | Revisions Net=+0 | Growth EPS=+10.6% | Growth Revenue=+3.1%
EPS next Year (2027-09-30): EPS=0.99 | Chg30d=+0.030 | Revisions Net=+1 | Growth EPS=+17.9% | Growth Revenue=+3.9%
P/E Trailing = 10.3701
P/E Forward = 21.0084
P/S = 0.3792
P/B = 1.1599
Revenue TTM = 6.94b EUR
EBIT TTM = 258.7m EUR
EBITDA TTM = -1.08b EUR
Long Term Debt = 480.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 151.2m EUR (from shortTermDebt, last quarter)
Debt = 846.1m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 682.8m EUR (from netDebt column, last quarter)
Enterprise Value = 1.95b EUR (1.27b + Debt 846.1m - CCE 163.5m)
Interest Coverage Ratio = 4.13 (Ebit TTM 258.7m / Interest Expense TTM 62.6m)
EV/FCF = 7.68x (Enterprise Value 1.95b / FCF TTM 253.7m)
FCF Yield = 13.02% (FCF TTM 253.7m / Enterprise Value 1.95b)
FCF Margin = 3.65% (FCF TTM 253.7m / Revenue TTM 6.94b)
Net Margin = 2.83% (Net Income TTM 196.8m / Revenue TTM 6.94b)
Gross Margin = 32.45% ((Revenue TTM 6.94b - Cost of Revenue TTM 4.69b) / Revenue TTM)
Gross Margin QoQ = none% (prev 24.76%)
Tobins Q-Ratio = 0.76 (Enterprise Value 1.95b / Total Assets 2.57b)
Interest Expense / Debt = 2.26% (Interest Expense 19.1m / Debt 846.1m)
Taxrate = 24.15% (19.1m / 79.1m)
NOPAT = 196.2m (EBIT 258.7m * (1 - 24.15%))
Current Ratio = 1.10 (Total Current Assets 721.5m / Total Current Liabilities 653.7m)
Debt / Equity = 0.76 (Debt 846.1m / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = -0.63 (negative EBITDA) (Net Debt 682.8m / EBITDA -1.08b)
Debt / FCF = 2.69 (Net Debt 682.8m / FCF TTM 253.7m)
Total Stockholder Equity = 1.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.64% (Net Income 196.8m / Total Assets 2.57b)
RoE = 18.66% (Net Income TTM 196.8m / Total Stockholder Equity 1.05b)
RoCE = 16.85% (EBIT 258.7m / Capital Employed (Equity 1.05b + L.T.Debt 480.7m))
RoIC = 11.91% (NOPAT 196.2m / Invested Capital 1.65b)
WACC = 4.58% (E(1.27b)/V(2.11b) * Re(6.49%) + D(846.1m)/V(2.11b) * Rd(2.26%) * (1-Tc(0.24)))
Discount Rate = 6.49% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.06%
[DCF Debug] Terminal Value 85.89% ; FCFF base≈240.5m ; Y1≈230.2m ; Y5≈223.3m
Fair Price DCF = 37.95 (EV 6.70b - Net Debt 682.8m = Equity 6.01b / Shares 158.4m; r=5.90% [WACC]; 5y FCF grow -5.67% → 2.90% )
EPS Correlation: -29.14 | EPS CAGR: -47.07% | SUE: 0.0 | # QB: 0
Revenue Correlation: -11.09 | Revenue CAGR: -0.24% | SUE: 0.03 | # QB: 0
EPS current Year (2026-09-30): EPS=0.84 | Chg30d=+0.044 | Revisions Net=+0 | Growth EPS=+10.6% | Growth Revenue=+3.1%
EPS next Year (2027-09-30): EPS=0.99 | Chg30d=+0.030 | Revisions Net=+1 | Growth EPS=+17.9% | Growth Revenue=+3.9%